Pyrazinamide Supplier-Buyer Network — Trade Flow Analysis

Name: Pyrazinamide Supplier-Buyer Trade Network Dataset — 90+ Indian Exporters, 25+ Importers, 131+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Pyrazinamide supplier network, Pyrazinamide buyers, pharmaceutical export India, Pyrazinamide trade data

TransData Nexus

Pyrazinamide

India Pharmaceutical Trade Intelligence

$962.4M90 Suppliers131 CountriesHS 30049057

ExportsIndia → CONGO DR55.5%India → NIGERIA26.0%

ImportsUNITED STATES → India$5.0K GERMANY → India$2.6K

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

Who Supplies Pyrazinamide? Top Manufacturers & Buyers 2026 — LUPIN LIMITED Leads | TransData Nexus | TransData Nexus

1LUPIN LIMITED

LUPIN LIMITED is the first-largest Pyrazinamide exporter from India, with a market share of 81.8% and a total export value of $786.8M across 321 shipments. Their average shipment value of $2.5M is above the market average of $659.6K, suggesting premium or bulk contract pricing.

LUPIN LIMITED serves 5 named buyers in our database. CAMESKIN/CORDAID is the dominant customer, accounting for 67.6% of this supplier's tracked business. Top customers include:

• CAMESKIN/CORDAID — $532.0M across 217 shipments (67.6% of this supplier's total exports)

• NATIONAL TUBERCULOSIS AND LEPROSY C — $246.4M across 101 shipments (31.3% of this supplier's total exports)

• I+SOLUTIONS — $3.5M across 1 shipments (0.4% of this supplier's total exports)

• SEKRETARIAT DITJEN PENCEGAHAN DAN P — $2.6M across 1 shipments (0.3% of this supplier's total exports)

• DEPARTMENT OF HEALTH — $2.4M across 1 shipments (0.3% of this supplier's total exports)

Key Insight: LUPIN LIMITED's per-shipment value of $2.5M is 272% above the market average of $659.6K, consistent with large-order contracts or value-added formulations.

2MACLEODS PHARMACEUTICALS LTD

MACLEODS PHARMACEUTICALS LTD is the second-largest Pyrazinamide exporter from India, with a market share of 9.3% and a total export value of $89.7M across 361 shipments. Their average shipment value of $248.6K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.

MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. LA PHARMACIE CENTRALE DE TUNISIE is the dominant customer, accounting for 87.4% of this supplier's tracked business. Top customers include:

• LA PHARMACIE CENTRALE DE TUNISIE — $78.4M across 316 shipments (87.4% of this supplier's total exports)

• ATLANTA MEDICARE CO, — $3.5M across 14 shipments (3.9% of this supplier's total exports)

• MINISTRY OF HEALTH OF THE REPUBLIC — $3.4M across 14 shipments (3.8% of this supplier's total exports)

• MINISTERIO DA SAUDE/DEPARTAMENTO DE — $2.8M across 11 shipments (3.2% of this supplier's total exports)

• MEDECINS SANS FRONTIERES LOGISTIQUE — $1.6M across 6 shipments (1.7% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LTD operates with high shipment frequency (361 shipments) at a per-shipment value of $248.6K, indicating a broad distribution network with many smaller, regular orders.

3MACLEODS PHARMACEUTICALS LIMITED

MACLEODS PHARMACEUTICALS LIMITED is the third-largest Pyrazinamide exporter from India, with a market share of 0.4% and a total export value of $4.1M across 143 shipments. Their average shipment value of $28.7K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.

MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• NATIONAL COORDINATOR — $1.4M across 47 shipments (33.0% of this supplier's total exports)

• MACLEODS PHARMACEUTI — $922.2K across 32 shipments (22.5% of this supplier's total exports)

• ADVANCED PHARMACEUTI — $814.3K across 28 shipments (19.8% of this supplier's total exports)

• PERMANENT SECRETARY — $524.5K across 18 shipments (12.8% of this supplier's total exports)

• NA — $491.2K across 17 shipments (12.0% of this supplier's total exports)

Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (143 shipments) at a per-shipment value of $28.7K, indicating a broad distribution network with many smaller, regular orders.

4SVIZERA LABS PRIVATE LIMITED

SVIZERA LABS PRIVATE LIMITED is the fourth-largest Pyrazinamide exporter from India, with a market share of 0.3% and a total export value of $3.0M across 39 shipments. Their average shipment value of $75.9K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.

SVIZERA LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR LABARAN SHEHU — $1.0M across 13 shipments (34.1% of this supplier's total exports)

• MOH- NATIONAL TB AND — $625.4K across 8 shipments (21.1% of this supplier's total exports)

• TO THE ORDER OF — $622.4K across 8 shipments (21.0% of this supplier's total exports)

• NATIONAL TUBERCULOSIS AND LEPROSY C — $541.2K across 7 shipments (18.3% of this supplier's total exports)

• MINISTERIO DE SALUD — $162.7K across 2 shipments (5.5% of this supplier's total exports)

Key Insight: SVIZERA LABS PRIVATE LIMITED operates with high shipment frequency (39 shipments) at a per-shipment value of $75.9K, indicating a broad distribution network with many smaller, regular orders.

5MANEESH PHARMACEUTICALS LIMITED

MANEESH PHARMACEUTICALS LIMITED is the fifth-largest Pyrazinamide exporter from India, with a market share of 0.3% and a total export value of $2.7M across 69 shipments. Their average shipment value of $39.3K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.

MANEESH PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• 5 KAMPALA — $822.1K across 21 shipments (30.3% of this supplier's total exports)

• SOCINTER- SOCIEDADE — $745.3K across 19 shipments (27.5% of this supplier's total exports)

• KENYA MEDICAL SUPPLIES AGENCY — $417.9K across 11 shipments (15.4% of this supplier's total exports)

• SEKRETARIAT DITJEN PENCEGAHAN DAN P — $390.0K across 10 shipments (14.4% of this supplier's total exports)

• KENYA MEDICAL SUPPLIES AGENCY — $335.0K across 9 shipments (12.4% of this supplier's total exports)

Key Insight: MANEESH PHARMACEUTICALS LIMITED operates with high shipment frequency (69 shipments) at a per-shipment value of $39.3K, indicating a broad distribution network with many smaller, regular orders.

6MICRO LABS LIMITED

MICRO LABS LIMITED is the fifth-largest Pyrazinamide exporter from India, with a market share of 0.1% and a total export value of $1.1M across 64 shipments. Their average shipment value of $16.5K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• D.G. CENTRAL MEDICAL — $316.0K across 19 shipments (29.9% of this supplier's total exports)

• PROGRAMA DE LAS NACI — $266.0K across 16 shipments (25.1% of this supplier's total exports)

• PHARMACIE CENTRALE D — $194.3K across 12 shipments (18.4% of this supplier's total exports)

• PHARMACE NATIONALE — $167.0K across 10 shipments (15.8% of this supplier's total exports)

• THE MEDICAL EXPORT G — $114.7K across 7 shipments (10.8% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (64 shipments) at a per-shipment value of $16.5K, indicating a broad distribution network with many smaller, regular orders.

1Congo Dr

Congo Dr ranks as the first-largest destination for Pyrazinamide imports from India, with a total trade value of $534.5M across 0 shipments — representing a 55.5% share of all Pyrazinamide exports. The average shipment value of $534.5M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations.

Key Insight: Congo Dr's per-shipment average of $534.5M (80936% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Congo Dr is a key market for Pyrazinamide imports from India.

Primary Market

Secondary Market

2Nigeria

Nigeria ranks as the second-largest destination for Pyrazinamide imports from India, with a total trade value of $250.0M across 44 shipments — representing a 26.0% share of all Pyrazinamide exports. The average shipment value of $5.7M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Pyrazinamide importers in Nigeria: NATIONAL TUBERCULOSIS AND LEPROSY is the largest buyer, accounting for 98.9% ($247.2M) of this market's total imports.

• NATIONAL TUBERCULOSIS AND LEPROSY — $247.2M (98.9% of Nigeria's total)

• NATIONAL TUBERCULOSIS AND LEPROSY C — $1.7M (0.7% of Nigeria's total)

Key Insight: Nigeria's per-shipment average of $5.7M (761% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Nigeria is a key market for Pyrazinamide imports from India.

Primary Market

Secondary Market

3Tunisia

Tunisia ranks as the third-largest destination for Pyrazinamide imports from India, with a total trade value of $78.5M across 3 shipments — representing a 8.2% share of all Pyrazinamide exports. The average shipment value of $26.2M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Pyrazinamide importers in Tunisia: LA PHARMACIE CENTRALE DE TUNISIE is the largest buyer, accounting for 100.0% ($78.4M) of this market's total imports.

• LA PHARMACIE CENTRALE DE TUNISIE — $78.4M (100.0% of Tunisia's total)

Key Insight: Tunisia's per-shipment average of $26.2M (3866% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tunisia is a key market for Pyrazinamide imports from India.

Primary Market

Secondary Market

4Netherlands

Netherlands ranks as the fourth-largest destination for Pyrazinamide imports from India, with a total trade value of $9.7M across 52 shipments — representing a 1.0% share of all Pyrazinamide exports. The average shipment value of $187.0K is below the global average of $659.6K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Pyrazinamide importers in Netherlands: I+SOLUTIONS is the largest buyer, accounting for 70.0% ($6.8M) of this market's total imports.

• I+SOLUTIONS — $6.8M (70.0% of Netherlands's total)

Key Insight: Netherlands receives frequent, smaller shipments of Pyrazinamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Netherlands is a key market for Pyrazinamide imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Pyrazinamide imports from India, with a total trade value of $8.6M across 35 shipments — representing a 0.9% share of all Pyrazinamide exports. The average shipment value of $246.7K is below the global average of $659.6K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Pyrazinamide importers in South Africa: UPD LEA GLEN is the largest buyer, accounting for 20.4% ($1.8M) of this market's total imports.

• UPD LEA GLEN — $1.8M (20.4% of South Africa's total)

• UPD LEA GLEN, PHARMA DYNAMICS C/O — $1.7M (20.2% of South Africa's total)

Key Insight: South Africa receives frequent, smaller shipments of Pyrazinamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

South Africa is a key market for Pyrazinamide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pyrazinamide.
2.Flow Mapping: 90 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,459 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 131 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,459 Verified Shipments

90 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Pyrazinamide

Pyrazinamide

Who Supplies Pyrazinamide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Pyrazinamide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Pyrazinamide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1LUPIN LIMITED

2MACLEODS PHARMACEUTICALS LTD

3MACLEODS PHARMACEUTICALS LIMITED

4SVIZERA LABS PRIVATE LIMITED

5MANEESH PHARMACEUTICALS LIMITED

6MICRO LABS LIMITED

From Indian Factories to Global Pharmacies — How Pyrazinamide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Pyrazinamide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Congo Dr

2Nigeria

3Tunisia

4Netherlands

5South Africa

People Also Ask — Pyrazinamide Supplier & Trade Network

Pyrazinamide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology